Kerala Ayurveda ‘s Q2 Financial results: Revenue Grows by 21.73% YoY

The comprehensive analytics outlining the performance and outlook of Kerala Ayurveda Limited‘s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Today, we’re looking at Kerala Ayurveda Limited’s financial performance for the Q2(Sep 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 21.73 %. However, it did see a marginal increase of 15.93 % from the previous quarter. Expenses decreased slightly by -1.31 % quarter-on-quarter, aligning with the annual rise of 2.69 %. Operating profit, while up 924.07 % compared to last year, faced a quarter-on-quarter increase of 591.25 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 15.3 %, but an expansion of 14.45 % sequentially. Other income rose by 189.14 % compared to the last quarter, despite an annual decline of -17.23 %. Interest expenses surged remarkably by 56.52 % from the previous quarter, yet the year-over-year increase remains at a moderate 10.77 %. Depreciation costs climbed by 450 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 518.75 %. Profit before tax grew annually by 920.59 % but saw an increase from the preceding quarter by 1635 %.
Tax expenses as a percentage of profits decreased slightly by -94.73 % compared to last year, with a more notable quarter-on-quarter decrease of -115.12 %. but experienced a 693.48 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 528.57 % but a quarterly fall of -9.09 %. In summary, Kerala Ayurveda Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

In reviewing Kerala Ayurveda Limited’s 2024-25(Q2) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 21.73 % year-on-year growth, however, there was a minor increase of 15.93 % from the previous quarter. Expenses rose by 2.69 % compared to the previous year, with a decrease of -1.31 % quarter-on-quarter. Operating Profit surged by 924.07 % annually, and saw a 591.25 % increase from the last quarter.
and experienced a 693.48 % increase from the previous quarter. Earnings Per Share (EPS) rose by 528.57 % annually, however dipped by -9.09 % compared to the last quarter. In essence, while Kerala Ayurveda Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.